Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
Pattern hair loss affects an estimated 50 million men and 30 million women in the U.S., but there have been no new approved drugs since the late 1990s.
Pattern hair loss affects an estimated 50 million men and 30 million women in the U.S., but there have been no new approved drugs since the late 1990s.
No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.
Pattern hair loss affects an estimated 50 million men and 30 million women in the U.S., but there have been no new approved drugs since the late 1990s.